Trump Portfolio Traded UnitedHealth Stock Around 2.5% Medicare Rate Shift

A federal disclosure reveals over 3,600 stock trades in the first quarter by accounts tied to Donald Trump, with significant trading in healthcare stocks perfectly timed around market-moving regulatory announcements.

Investment managers for Donald Trump actively traded shares of UnitedHealth Group and other major insurers this year, executing large sales after a proposed Medicare payment rate sent the stock down 20% and buying back before a favorable policy reversal sparked a 9% rally.

"No president that I know of has ever had this type of extensive trading in securities while he’s in office," said University of Minnesota law professor Richard Painter, a former chief ethics lawyer for the White House during the George W. Bush administration. "I’ve never seen anything like this before."

Disclosures released by the U.S. Office of Government Ethics show Trump's portfolio sold up to $5 million in UnitedHealth stock shortly after a disappointing Jan. 26 Medicare proposal. The accounts then made nine separate purchases worth up to $410,000 in the insurer's shares between Feb. 23 and March 23, positioning them to gain from an April 6 policy revision that boosted the 2027 payment rate increase to 2.48% from a proposed 0.09%.

The trades raise significant conflict-of-interest questions, as the president has direct influence over regulatory bodies like the federal Medicare agency. While stock trading by a sitting president is not explicitly illegal—the federal criminal conflict of interest statute does not apply to the office—the pattern of transactions preceding beneficial policy outcomes could trigger heightened regulatory scrutiny for the entire health services sector.

Conflicting statements from the president’s representatives have clouded the issue of who directs the investments. The Trump Organization stated the portfolio is managed by "independent, third party financial institutions" with no input from Trump. However, a White House spokesperson previously claimed the assets are in a "trust managed by his children," while Eric Trump posted on social media that they are "invested blindly... in broad market indexes." These claims are contradicted by the disclosure itself, which the president personally signed, certifying he has "full knowledge" of the more than 3,600 individual stock trades listed.

A Pattern of Questionable Trades

The activity in UnitedHealth was not an isolated event. The portfolio also traded other health insurance stocks subject to federal policy shifts. It sold up to $330,000 in Humana stock in February before buying up to $130,000 in March.

Another notable trade involved Elevance Health. The portfolio sold between $265,000 and $550,000 of the company's shares on March 17 and 18. This came after Elevance was notified in February of possible sanctions from the Medicare agency over data submission compliance, a development that caused its stock to fall more than 8%.

A Break From Precedent

The sheer volume of trading marks a stark departure from the practices of most modern presidents, who typically divest from individual stocks to avoid even the appearance of impropriety. Jimmy Carter placed his peanut farm into a blind trust, and Ronald Reagan divested his holdings upon taking office.

Ethics experts argue that a president's awareness of their specific investments can subconsciously influence decision-making, creating scenarios where official actions could benefit their personal portfolio. Dylan Hedtler-Gaudette of the Project On Government Oversight said having Trump's children manage the investments "leaves open the possibility that Trump and his family are corruptly benefiting financially from Trump's time in office." The situation is made more ironic by the president's own calls in February for Congress to pass stock trading bans for its members to prevent profiting from insider information.

This article is for informational purposes only and does not constitute investment advice.